The Living Guidelines: Patients with Wolff Parkinson White syndrome (WPW): Polling Results for CLASS III Guidelines

Jump to navigation Jump to search

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Any recommendations found on these pages are for education use only. WikiDoc is not a substitute for a licensed healthcare provider. Please see the disclaimers page for important information regarding limitations of the information found here. In suggesting edits to the guidelines, WikiDoc suggests that the following classification scheme be used. Read more about the classification scheme used by the ACC / AHA Guidelines Committee here.

Class III Guidelines

1. Intravenous administration of digitalis glycosides or non dihydropyridine calcium channel antagonists is not recommended in patients with WPW syndrome who have pre-excited ventricular activation during AF. (Level of Evidence: B) [1]

<Poll> ACC / AHA 2008 guidelines for diagnosis and management of atrial fibrillation: Class III Recommendation 1 for patients with Wolff Parkinson White syndrome (WPW) should be: CLASS I CLASS IIa CLASS IIb CLASS III </poll>

References

  1. Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Le Heuzey JY, Kay GN, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann S. ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation- Executive Summary: executive summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidlines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society. Circulation. 2006; 114: 700-752. PMID 16908781

Template:WikiDoc Sources